Osteoporotic fracture prevention: An individual and economic approach;Effet des différents traitements de l'ostéoporose sur la prévention de la fracture: Vers une approche individuelle et économique

Praxis

Volumn 93, Issue 11, 2004, Pages 399-405

  Lamy, O ^a   Krieg, M A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Calcium and vitamin D; Number needed to treat; Osteoporosis; QALY

Indexed keywords

EID: 80051769931     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.93.11.399     Document Type: Review

References (18)

1. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282: 637-45. (Pubitemid 29384151)
2. Black DM, Thompson DE, Bauer DC, et al. Fracture Intervention Trial. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000; 85: 4118-24. (Pubitemid 32055362)
3. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-42.
4. Lieberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Eng J Med 1995; 333: 1437-43.
5. Black DM, Cummings Sr, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 1535-41.
6. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomised controlled trial. JAMA 1999; 282: 1344-52. (Pubitemid 29483192)
7. McClung MR, Geusens P, Miller PD, et al. Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001; 344: 333-40.
8. Reid IR, Brown JP, Burckhardt P, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002; 346: 653-61. (Pubitemid 34815869)
9. Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray calcitonin in postmenopausal women with established osteoporosis: the recurrence of osteoporotic fractures study. Am J Med 2000; 109: 267-76.
10. Lyritis GP, Tsakalakos N, Magiasis B, et al. Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures : a double-blinded placebo-controlled clinical study. Calcif Tissue Int 1991; 49: 369-7.
11. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2000; 344: 1434-41.
12. Meunier PJ, Slosman DO, Delmas PD, et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis. A 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 2002; 87: 2060-6.
13. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33. (Pubitemid 34761611)
14. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001; 12: 989-95. (Pubitemid 34105967)
15. Melton LJ 3rd, Atkinson EJ, Cooper C, et al. Vertebral fractures predict subsequent fractures. Osteoporos Int 1999; 10: 214-21. (Pubitemid 29458716)
16. Lamy O, Krieg MA, Burckhardt P. Les indications au traitement de l'ostéoporose.Rev Med Suisse Rom 2002; 122: 383-7.
17. Lamy O, Krieg MA, Burckhardt P, et al. An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women. Expert Opin Pharmather 2003 (in press).
18. Kanis JA, Brazier JE, Stevenson M, et al. Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 2002; 6: 1-146.